Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dialysis solution containing dextrose and electrolytes; dextrose provides osmotic gradient for ultrafiltration and caloric supplementation, while electrolytes maintain acid-base and electrolyte balance in peritoneal dialysis.
Provides osmotic gradient for peritoneal dialysis; glucose and icodextrin facilitate ultrafiltration and removal of waste products across the peritoneal membrane.
Intravenous infusion, 500-2000 mL per day as maintenance fluid; rate adjusted based on clinical status, typically 1-2 mL/kg/hour in adults.
2 L intraperitoneally via an indwelling peritoneal catheter, dwell time 4-6 hours, 4 exchanges per day
None Documented
None Documented
Terminal half-life: 2.5–3.5 hours. Clinically, this allows for rapid clearance; accumulation may occur in renal impairment.
Not applicable as a traditional half-life; removal is dependent on peritoneal dialysis dwell time and membrane transport characteristics. Effective clearance half-life during dialysis is approximately 2-4 hours depending on exchange schedule.
Renal: >95% as unchanged drug and metabolites. Biliary/fecal: <5%.
Primarily removed via peritoneal dialysis; minimal renal excretion (less than 5% unchanged). Dextrose is metabolized to CO2 and water. Biliary/fecal excretion negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution